Trastuzumab and Cardiac Outcomes in Breast Cancer: A Story We Know by Heart?

JAMA Oncol. 2016 Jan;2(1):21-2. doi: 10.1001/jamaoncol.2015.3866.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biomarkers, Tumor / antagonists & inhibitors*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Paclitaxel / adverse effects*
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Stroke Volume / drug effects*
  • Trastuzumab / adverse effects*
  • Ventricular Dysfunction, Left / chemically induced*
  • Ventricular Function, Left / drug effects*

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2
  • Trastuzumab
  • Paclitaxel